Prostate Cancer Focal Therapy Modalities, Maps and Margins: Optimizing Oncologic Efficacy
Mark Emberton, MD, FRCS, discusses current technologies and modern lesion management strategies for destroying prostate cancer cells.
▶︎
MRI-invisible lesions and low-risk prostate cancer
▶︎
Prostate Cancer: What You NEED To Know
▶︎
Critical Debate: Focal Therapy vs. Whole Gland Treatment for Prostate Cancer PGG 2/3
▶︎
Focal Therapy For #ProstateCancer | Answering Your Questions | #MarkScholzmd #AlexScholz #PCRI
▶︎
Margin Width and Local Recurrence - Does it Matter?
▶︎
Treatment of Prostate Cancer: PSMA PET at Low PSA - Solitary Suspicious Lesion after Radiation & ADT
▶︎
Gleason 7 (4+3) #prostatecancer Treatments and Side Effects | #markscholzmd | PCRI
▶︎
Metastatic Prostate Cancer: What It Really Means (Not What You Think)
▶︎
Focal Therapy for Prostate Cancer: How to follow patients after treatment?
▶︎
Focal Therapy in Prostate Cancer
▶︎
Treatment of Prostate Cancer: Approaches in Localized Disease - Experts Discuss
▶︎
Can AI Replace the Prostate Biopsy? Dr. Wayne Brisbane on the Future - EP. 184
▶︎
(6) Prostate Focal Therapy Summarized for the 2019 California Prostate Cancer Coalition Meeting
▶︎
Why Prostate Cancer Doctors DISAGREE About the "Best" Treatment
▶︎
Why NOT radiation for prostate cancer?
▶︎
Radical prostatectomy vs radiation therapy
▶︎
The Lancet's Biggest Prostate Cancer Update in 10 Years Changes Everything
▶︎
4.30.2020 Urology COViD Didactics - Treatment for Clinically Localized Prostate Cancer
▶︎
Active Surveillance for Early-Stage Prostate Cancer
▶︎